Investment Rating - The report assigns a "Buy" rating to the company 康方生物 (9926 HK) with a target price raised to HKD 140.00, indicating a potential upside of 29.3% from the current price of HKD 108.30 [2][12][13]. Core Insights - The company is advancing multiple indications for its drug 依沃西, with a significant focus on I/O and ADC strategies, which are expected to differentiate its offerings in the market [2][7]. - The report highlights the promising overseas approval prospects for 依沃西, particularly for its application in treating 2L+ EGFRm NSCLC, as the efficacy shown in the HARMONi study surpasses existing chemotherapy options [7]. - 康方生物 is also initiating several Phase III studies in mainland China for various cancers, indicating a broadening of its therapeutic scope [7]. - The report anticipates a peak sales adjustment for 依沃西 in China to RMB 7.1 billion [7]. - The company is starting overseas development for 卡度尼利, with a recent approval for a new indication in first-line cervical cancer, and plans for a Phase II study in second-line liver cancer [7]. - The ADC development strategy is gaining traction, with the first ADC (HER3) entering clinical trials and the first bispecific ADC AK146D1 completing patient enrollment [7]. - The report emphasizes the rich pipeline of catalysts, including upcoming data releases and negotiations for multiple products in Q4 2025 [7]. Financial Overview - The company’s projected revenues for 2025 are estimated at RMB 3,506 million, with a significant growth trajectory expected in subsequent years, reaching RMB 8,053 million by 2027 [6][15]. - The net profit is projected to recover to RMB 402 million in 2025, with further increases anticipated in the following years [6][15]. - The report notes a substantial year-to-date stock price increase of 78.42% [4]. - The company’s market capitalization stands at approximately HKD 97.08 billion [4]. Valuation Model - The DCF valuation model indicates an equity value of RMB 114,241 million, translating to a per-share value of HKD 140.00 [9]. - The report reflects adjustments in revenue forecasts, with a decrease in expected revenues for 2025 and 2026 compared to previous estimates [8]. Market Position - 康方生物 is positioned within the biotechnology sector, focusing on innovative therapies that leverage both I/O and ADC technologies, aiming to capture new market opportunities [2][12]. - The report suggests that the company’s strategic initiatives and product pipeline could lead to sustained long-term value creation [7].

Group 1: Core Insights - The report highlights that certain technology stocks have reached all-time highs, suggesting investors continue to focus on AI investment themes [1] - The global stock market remains strong, with technology stocks outperforming the broader market, as evidenced by the MSCI Global Index and Nasdaq 100 rebounding approximately 24% and 31% respectively since April 7 [1] - TSMC's June revenue increased by 27% year-on-year, with expectations for continued technological advantages as it enters 2nm mass production in the second half of 2025 [1] Group 2: Industry Trends - Storage prices are expected to continue rising in the second half of 2025, with DDR4 contract prices showing significant increases and DDR5 spot prices recovering rapidly since June [2] - The report anticipates that the ongoing inventory replenishment, following tariff relief, will maintain upward pressure on storage prices, impacting costs for smartphones and consumer electronics [2] - Investment recommendations include focusing on AI infrastructure development while diversifying investments based on valuation, with a particular emphasis on domestic semiconductor companies and the domestic substitution process for semiconductor equipment [2] Group 3: Economic Data - The report outlines upcoming economic data releases for the U.S. and China, including consumer credit and unemployment claims in the U.S., and consumer price indices and trade surplus in China [4]

Group 1: Core Insights - The retail sales of passenger cars in June reached 2.084 million units, showing a year-on-year increase of 18.1% and a month-on-month increase of 7.6% [1] - The cumulative retail sales for the first half of the year amounted to 10.901 million units, reflecting a year-on-year growth of 10.8% [1] - The penetration rate of new energy vehicles (NEVs) in June reached 53.3%, marking a month-on-month increase of 0.4 percentage points and a new high for the year [1] Group 2: New Energy Vehicle Performance - In the first half of 2025, the penetration rate of NEVs was 50.1%, with retail sales in June reaching 1.111 million units, which is a year-on-year increase of 29.7% and a month-on-month increase of 8.2% [1] - NEVs accounted for 41.1% of total vehicle exports in June, an increase of 17 percentage points compared to the same period last year [1] Group 3: Market Outlook and Recommendations - The market is expected to see stable growth in July, with several new models set to launch, including XPeng G7, Ledo L90, Li Auto i8, and BYD Sea Lion 06 [2] - Investment recommendations include focusing on BYD (1211 HK) for its intelligent driving and export potential, XPeng Motors (9868 HK/XPEV US) for its new model launches, and Geely Auto (175 HK) for internal resource integration following the privatization of Zeekr [2]

Industry Investment Rating - The automotive industry is rated as "Leading" [1] Core Insights - In June, the penetration rate of new energy vehicles (NEVs) rose to 53.3%, with expectations for stable growth in the car market in July [1][4] - Retail sales of passenger cars in June reached 2.084 million units, representing a year-on-year increase of 18.1% [4] - Domestic brands outperformed the overall industry, with retail sales of 1.34 million units in June, a year-on-year increase of 30% [4] - The export of passenger cars showed a slowdown, but NEV exports maintained good growth, accounting for 41.1% of total exports in June [4] Summary by Relevant Sections Market Performance - The passenger car market in June showed a positive trend, benefiting from consumer promotion policies and financial support [4] - The cumulative retail sales of passenger cars in the first half of the year reached 10.901 million units, up 10.8% year-on-year [4] New Energy Vehicles - The NEV penetration rate for the first half of 2025 reached 50.1%, with June sales of 1.111 million units, a year-on-year increase of 29.7% [4] - Domestic brands accounted for 75.4% of the NEV penetration rate in June, with a market share of 71% [4] Investment Recommendations - The report suggests focusing on companies like BYD (1211 HK), XPeng Motors (9868 HK), and Geely (175 HK) due to their expected growth in sales and profitability [4]

Investment Rating - The investment rating for the company is downgraded to "Neutral" from a previous rating due to limited valuation attractiveness after a significant stock price increase [2][7]. Core Views - The approval of a private placement will alleviate the company's financial pressure, with plans to raise RMB 3.5 billion, primarily for a solar cell project [7]. - The company is expected to significantly reduce losses in Q2 2025 due to a higher sales proportion of premium BC components in overseas markets [7]. - The supply side of the photovoltaic industry is anticipated to improve following recent government meetings aimed at regulating low-price competition and enhancing product quality [7]. - The target price for the company has been raised to RMB 16.50, reflecting an increase in valuation from 14 times to 18 times the 2026 earnings [7]. Financial Overview - Revenue projections show a decline in 2023 to RMB 27,170 million, followed by a significant drop in 2024 to RMB 11,155 million, before rebounding to RMB 22,800 million in 2025 [3][11]. - Net profit is expected to be negative in 2024 at RMB (5,319) million, with a gradual recovery projected in subsequent years, reaching RMB 2,622 million by 2027 [3][11]. - The company's earnings per share (EPS) is forecasted to be negative in 2024 at RMB (2.91), with a return to positive EPS of RMB 1.43 by 2027 [3][11]. - The price-to-earnings (P/E) ratio is projected to be 35.3 in 2023, with a significant drop to 10.2 by 2027, indicating a potential recovery in profitability [3][11]. Stock Performance - The stock has shown a year-to-date increase of 32.76%, with a 52-week high of RMB 16.49 and a low of RMB 7.39 [6][10]. - The average daily trading volume is reported at 78.98 million shares, indicating active trading interest [6].

Group 1: Company Overview - The report highlights that the company, Aisuo Co., Ltd. (爱旭股份), has received approval for a private placement of funds, which is expected to alleviate its financial pressure significantly [1] - The company's asset-liability ratio reached 86.0% in Q1 2025, and the estimated fundraising of 3.5 billion RMB is projected to reduce this ratio by 9.6 percentage points [1] - Following a 40% increase in stock price since the rating upgrade on April 30, the report suggests that the current valuation is no longer attractive, leading to a downgrade to a neutral rating [1] Group 2: Market Performance - The report anticipates that over 40% of the company's ABC components will be sold in higher-priced overseas markets in Q2, which is expected to significantly reduce losses for the quarter [1] - Recent statements from central government officials emphasize the orderly exit of outdated production capacity, indicating a potential turning point for the photovoltaic supply side [1] Group 3: Stock and Valuation - The closing price of Aisuo Co., Ltd. is reported at 14.63 RMB, with a target price raised to 16.50 RMB, indicating a potential upside of 12.8% [1] - The report notes that further valuation improvement is contingent upon the implementation of substantial policies [1]

Group 1: Core Insights - Meituan's daily order volume for instant retail exceeded 120 million, with food delivery surpassing 100 million and Meituan Flash Purchase exceeding 20 million [1][2] - The company has increased its delivery subsidies in June, leading to an estimated 16% year-on-year decline in CLC operating profit, but food delivery order growth is expected to rise from mid-single digits to 10% [1][2] - Despite ongoing subsidy wars, Meituan is likely to maintain operational profit stability, with a target price of HKD 165, indicating a potential upside of 36.6% from the current price of HKD 120.80 [1][2] Group 2: Financial Projections - The average order value (AOV) may decline due to the subsidy competition, which could further slow revenue growth [2] - CLC revenue growth is projected to remain at 10% year-on-year, with profits expected to decrease by 9% [2] - The closure of Meituan Youxuan's loss-making areas could release approximately 3-4 billion yuan to support future delivery subsidies [2] Group 3: Market Position - Meituan continues to hold a leading position in the food delivery market, with strong operational capabilities and a high likelihood of maintaining market share [1][2] - The company’s operational and dispatch efficiency remains crucial for sustaining its market dominance [2]

交银国际研究 公司更新 | 互联网 | 收盘价 | | 目标价 | | 潜在涨幅 | 2025 年 7 月 7 日 | | --- | --- | --- | --- | --- | --- | --- | | 港元 | | 120.80 | 港元 | 165.00 | +36.6% | | | 美团 (3690 HK) | | | | | | | 外卖日单峰值突破 1 亿，运营能力仍有优势，维持买入 财务数据一览 | 年结12月31日 | 2023 | 2024 | 2025E | 2026E | 2027E | | --- | --- | --- | --- | --- | --- | | 收入 (百万人民币) | 276,745 | 337,592 | 386,213 | 437,899 | 474,235 | | 同比增长 (%) | 25.8 | 22.0 | 14.4 | 13.4 | 8.3 | | 净利润 (百万人民币) | 23,253 | 43,772 | 43,485 | 58,982 | 66,969 | | 每股盈利 (人民币) | 3.71 | 7.00 | 7.01 | 9.51 ...

Global Macro - Strong non-farm payroll data supports the Federal Reserve's wait-and-see stance, with June non-farm employment increasing by 147,000, exceeding market expectations of 110,000. The unemployment rate unexpectedly fell to 4.1% [1][2] - Average hourly wage growth year-on-year decreased to 3.7%, with a month-on-month increase slowing to 0.2%. This strong employment data reduces the urgency for interest rate cuts in the short term [1][2] Automotive Industry - XPeng Motors launched the G7 model at a starting price of 195,800 yuan, which is 40,000 yuan lower than the pre-sale price, exceeding expectations [3] - The G7 focuses on family comfort and smart technology, showcasing competitive advantages in the mid-to-high-end pure electric SUV market compared to competitors like Model Y and Xiaomi YU7 [3][6] - XPeng's sales in the first half of 2025 exceeded 197,000 units, a year-on-year increase of 279%, achieving 56% of its annual target. The G7's launch is expected to sustain sales growth in the second half of the year [6] Internet Industry - Tencent's mobile game revenue is expected to grow by 17% in Q2, while NetEase's mobile game revenue shows positive year-on-year growth, with domestic revenue increasing by 4% [9][10] - The performance of Tencent's games was impacted by a high base from previous releases, while new games like "Delta Action" and established titles contributed to mitigating losses [10] Economic Data - Upcoming economic data releases include U.S. consumer credit and unemployment claims, as well as China's consumer price index and trade surplus figures [11]

交银国际研究 宏观策略 2025 年 7 月 4 日 全球宏观 劳动力参与率三连降推动失业率意外放缓。6 月新增就业呈现出明显的结构性 特征：政府裁员、人工智能发展驱使科技行业主动裁员，压缩了对行政类和高 技能劳动者的需求。另一方面，特朗普政府收紧移民政策削弱了低技能劳动力 供给，使得部分服务型、劳动密集型行业面临人手短缺。新增移民锐减趋势 下，劳动力供给的减少意味着失业率分母基数的下降，也解释了为何在新增就 业放缓的背景下，失业率仍能从 4.2%回落至 4.1%，主要是由于劳动参与率 （由 4 月的 62.6%放缓至 6 月的 62.3%）下降而非就业需求的实质性改善。 后市观察：当前的经济数据格局为美联储维持观望立场提供了充分支撑。尽管 特朗普持续施压要求降息，并尽早提名新的美联储主席，且美联储主席鲍威尔 本周虽然表示 7 月降息选项"未排除"，但这更多是一种策略性表态，而非政 策立场的实质性转变。从技术层面看，领先指标的初请失业金人数仍维持在相 对较低位置，劳动力市场韧性依然存在。美联储当前的核心关切仍是防范通胀 风险，特别是关税政策可能带来的夏季价格上涨压力。在经济基本面尚能承 受、劳动力市场保持相对 ...